Switchpoint Bio

Switchpoint Bio is a TechBio startup building a blood-based epigenomics platform for drug developers. Combining targeted DNA methylation profiling with AI, it reads epigenomic marks carried by circulating immune cells to show how disease and treatment change human biology and which patients respond, aiming to monitor treatment without repeated tissue biopsies. Founded in 2025 by the team behind Blueprint Genetics and the inventor of ATAC-seq, it operates across Helsinki and Cambridge, Massachusetts, with first clinical validation in autoimmune disease such as systemic lupus erythematosus.

  • Pre-Seed
  • AI/ML
  • Biotechnology
  • Genomics
  • Healthtech
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Nov 11, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 11, 2026

    EUR 5.3M

    Pre-Seed

    Led by Treehouse Delmar Investments

    • Treehouse Delmar Investments

    Article coming soon.

Pricing

Research Switchpoint Bio — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Switchpoint Bio is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational